TNFRSF6B and Sepsis: All data suggest that DcR3 is likely to be an effective biomarker for: (1) early diagnosis of sepsis (before a pathogen-positive blood culture); (2) monitoring the effectiveness of treatment; and (3) predicting the clinical outcome of patients with sepsis.